Which one of the following antiretroviral switches involving non-nucleoside reverse transcriptase inhibitors (NNRTIs) has been shown in clinical trials to improve lipid profiles?
a. Doravirenz to efavirenz
b. Efavirenz to rilpivirine
c. Etravirine to efavirenz
d. Rilpivirine to efavirenz